<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34705216</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>29</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2523-899X</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Current medical science</Title><ISOAbbreviation>Curr Med Sci</ISOAbbreviation></Journal><ArticleTitle>Relationship Between Myocardial Injury and Expression of PGC-1α and Its Coactivators in Chronic Keshan Disease.</ArticleTitle><Pagination><StartPage>85</StartPage><EndPage>92</EndPage><MedlinePgn>85-92</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11596-021-2454-7</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Keshan disease (KD) is a mitochondrial cardiomyopathy. The present study explored the roles of peroxisome proliferator-activated receptor (PPAR)-γ coactivator-1α (PGC-1α), the key regulator of mitochondrial structure and function, and its coactivators in myocardial injury in chronic KD. Furthermore, the usefulness of these molecules in the diagnosis of chronic KD was assessed.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In the present case-control study, 43 patients with chronic KD and 30 healthy individuals living in KD endemic areas were included. The myocardial injury indicators and mRNA expression levels of PGC-1α, nuclear respiratory factor 1 (NRF1), PPARα, and estrogen-related receptor alpha (ERRα) in peripheral blood were examined.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">It was found that the levels of atrial natriuretic peptide, creatine kinase, and lactate dehydrogenase (LDH) were higher in patients with chronic KD, when compared to controls, while the level of bradykinin was lower. Furthermore, the PGC-1α, NRF1 and PPARα mRNA levels were higher in patients with KD. The area under the receiver operating characteristic curve and the optimal diagnostic threshold of LDH was 0.937 and 304.0 U/L, respectively. It is noteworthy that the area under the combined receiver operating characteristic curve was larger, when compared to that for LDH detection alone (Z=2.055, P=0.0399). The area under the curve for the "LDH+PPARα" combination was 0.984, with 96.7% sensitivity and 93.0% specificity.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The combined detection of LDH and the expression of PPARα can be performed to diagnose the chronic KD.</AbstractText><CopyrightInformation>© 2021. Huazhong University of Science and Technology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Jiang</LastName><ForeName>Shuai</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Keshan Disease, Chinese Center for Endemic Disease Control, Harbin Medical University, Harbin, 150081, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Affiliated Hospital of Jilin Medical College, Jilin, 132013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Ye</LastName><ForeName>Qian-Ru</ForeName><Initials>QR</Initials><AffiliationInfo><Affiliation>Institute of Keshan Disease, Chinese Center for Endemic Disease Control, Harbin Medical University, Harbin, 150081, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hangzhou Center for Disease Control and Prevention, Hangzhou, 310021, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhen</LastName><ForeName>Rong-Xia</ForeName><Initials>RX</Initials><AffiliationInfo><Affiliation>Sanya Institute of Technology, Sanya, 572022, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Juan-Niu</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Inner Mongolia Autonomous Region Mental Health Center, Hohhot, 010010, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yi-Yi</ForeName><Initials>YY</Initials><AffiliationInfo><Affiliation>Institute of Keshan Disease, Chinese Center for Endemic Disease Control, Harbin Medical University, Harbin, 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Institute of Keshan Disease, Chinese Center for Endemic Disease Control, Harbin Medical University, Harbin, 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Keshan Disease, Chinese Center for Endemic Disease Control, Harbin Medical University, Harbin, 150081, China. houjie@ems.hrbmu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Curr Med Sci</MedlineTA><NlmUniqueID>101729993</NlmUniqueID><ISSNLinking>2523-899X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C486497">PPARGC1A protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071248">Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.1.1.27</RegistryNumber><NameOfSubstance UI="D007770">L-Lactate Dehydrogenase</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C536166">Keshan disease</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="N">Cardiomyopathies</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007770" MajorTopicYN="N">L-Lactate Dehydrogenase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071248" MajorTopicYN="N">Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Keshan disease</Keyword><Keyword MajorTopicYN="N">lactate dehydrogenase</Keyword><Keyword MajorTopicYN="N">myocardial injury</Keyword><Keyword MajorTopicYN="N">peroxisome proliferator-activated receptor-γ coactivator-1α</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>27</Day><Hour>12</Hour><Minute>36</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34705216</ArticleId><ArticleId IdType="doi">10.1007/s11596-021-2454-7</ArticleId><ArticleId IdType="pii">10.1007/s11596-021-2454-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Loscalzo J. Keshan disease, selenium deficiency, and the selenoproteome. N Engl J Med, 2014,370(18):1756–1760</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcibr1402199</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang FY, Lin ZH, Li SG, et al. Keshan disease—an endemic mitochondrial cardiomyopathy in China. J Trace Elem Electrolytes Health Dis, 1988,2(3):157–163</Citation><ArticleIdList><ArticleId IdType="pubmed">2908794</ArticleId></ArticleIdList></Reference><Reference><Citation>Finck BN, Kelly DP. Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and disease. Circulation, 2007,115(19):2540–2548</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.107.670588</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsson NG, Wang JM, Wilhelmsson H, et al. Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat Genet, 1998,18(3):231–236</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0398-231</ArticleId></ArticleIdList></Reference><Reference><Citation>Vega RB, Huss JM, Kelly DP. The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol Cell Biol, 2000,20(5):1868–1876</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.20.5.1868-1876.2000</ArticleId></ArticleIdList></Reference><Reference><Citation>Huss JM, Torra IP, Staels B, et al. Estrogen-related receptor alpha directs peroxisome proliferator-activated receptor alpha signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle. Mol Cell Biol, 2004,24(20):9079–9091</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.24.20.9079-9091.2004</ArticleId></ArticleIdList></Reference><Reference><Citation>The Ministry of Health of the People’s Republic of China. Diagnosis of Keshan disease (WS/T 210-2011). Health industry standards of the People’s Republic of China. Beijing: Standards Press of China (Chinese), 2011</Citation></Reference><Reference><Citation>Duan SZ, Ivashchenko CY, Russell MW, et al. Cardiomyocyte-specific knockout and agonist of peroxisome proliferator-activated receptor-gamma both induce cardiac hypertrophy in mice. Circ Res, 2005,97(4):372–379</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.0000179226.34112.6d</ArticleId></ArticleIdList></Reference><Reference><Citation>Schupp M, Kintscher U, Fielitz J, et al. Cardiac PPARalpha expression in patients with dilated cardiomyopathy. Eur J Heart Fail, 2006,8(3):290–294</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejheart.2005.09.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabregat-Andrés Ó, Tierrez A, Mata M, et al. Induction of PGC-1α expression can be detected in blood samples of patients with ST-segment elevation acute myocardial infarction. PLoS One, 2011,6(11):e26913</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0026913</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhloba AA, Subbotina TF, Alekseevskaya ES, et al. The level of circulating PGC-1α in cardiovascular diseases. Biomed Khim (Russian), 2016,62(2):198–205</Citation><ArticleIdList><ArticleId IdType="doi">10.18097/PBMC20166202198</ArticleId></ArticleIdList></Reference><Reference><Citation>He SL, Tan WH, Zhang ZT, et al. Mitochondrial-related gene expression profiles suggest an important role of PGC-1alpha in the compensatory mechanism of endemic dilated cardiomyopathy. Exp Cell Res, 2013,319(17):2604–2616</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2013.07.018</ArticleId></ArticleIdList></Reference><Reference><Citation>Garnier A, Fortin D, Deloménie C, et al. Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J Physiol, 2003,551(Pt2):491–501</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2003.045104</ArticleId></ArticleIdList></Reference><Reference><Citation>Sihag S, Cresci S, Li AY, et al. PGC-1alpha and ERRalpha target gene downregulation is a signature of the failing human heart. J Mol Cell Cardiol, 2009,46(2):201–212</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2008.10.025</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao J. Study on the regulation mechanism of NO signaling pathway in mitochondrial biosynthesis of chronic hypoxia myocardial. The Third Military Medical University (Chinese), 2008</Citation></Reference><Reference><Citation>Hashimoto T, Hussien R, Oommen S, et al. Lactate sensitive transcription factor network in L6 cells: activation of MCT1 and mitochondrial biogenesis. FASEB J, 2007,21(10):2602–2612</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.07-8174com</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee HC, Yin PH, Chi CW, et al. Increase in mitochondrial mass in human fibroblasts under oxidative stress and during replicative cell senescence. J Biomed Sci, 2002,9(6Pt1):517–526</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02254978</ArticleId></ArticleIdList></Reference><Reference><Citation>St-Pierre J, Drori S, Uldry M, et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell, 2006,127(2):397–408</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2006.09.024</ArticleId></ArticleIdList></Reference><Reference><Citation>Turkieh A, Caubère C, Barutaut M, et al. Apolipoprotein O is mitochondrial and promotes lipotoxicity in heart. J Clin Invest, 2014,124(5):2277–2286</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI74668</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SK, Lee JO, Kim JH, et al. Coenzyme Q10 increases the fatty acid oxidation through AMPK-mediated PPARα induction in 3T3-L1 preadipocytes. Cell Signal, 2012,24(12):2329–2336</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2012.07.022</ArticleId></ArticleIdList></Reference><Reference><Citation>Merial C, Bouloumie A, Trocheris V, et al. Nitric oxide-dependent downregulation of adipocyte UCP-2 expression by tumor necrosis factor-α. Am J Physiol Cell Physiol, 2000,279(4):C1100–C1106</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.2000.279.4.C1100</ArticleId></ArticleIdList></Reference><Reference><Citation>Dröge W. Free radicals in the physiological control of cell function. Physiol Rev, 2002,82(1):47–95</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00018.2001</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Li L, Prabhakaran K, et al. Uncoupling protein-2 up-regulation and enhanced cyanide toxicity are mediated by PPARα activation and oxidative stress. Toxicol Appl Pharmacol, 2007,223(1):10–19</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.taap.2007.05.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins WE, Chen ZY, Fukagawa NK, et al. Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease: enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion. Circulation, 2004,109(23):2872–2877</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000129305.25115.80</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou LZ, Zhao Y, Yang TS. Characteristics of serum and myocardial zymograms in rats fed with grains of Keshan disease area. Endemic Dis Bull (Chinese), 1985,6(1):29–30</Citation></Reference><Reference><Citation>Yang X, Feng L, Zhang Y, et al. Co-exposure of silica nanoparticles and methylmercury induced cardiac toxicity in vitro and in vivo. Sci Total Environ, 2018,631–632:811–821</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scitotenv.2018.03.107</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Li W, Leng Y, et al. Ferroptosis is involved in diabetes myocardial ischemia/reperfusion injury through endoplasmic reticulum stress. DNA Cell Biol, 2020,39(2):210–225</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/dna.2019.5097</ArticleId></ArticleIdList></Reference><Reference><Citation>Houshmand F, Faghihi M, Zahediasl S. Role of atrial natriuretic peptide in oxytocin induced cardioprotection. Heart Lung Circ, 2015,24(1):86–93</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlc.2014.05.023</ArticleId></ArticleIdList></Reference><Reference><Citation>Prosser HC, Forster ME, Richards AM, et al. Urotensin II and urotensin II-related peptide (URP) in cardiac ischemia-reperfusion injury. Peptides, 2008,29(5):770–777</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.peptides.2007.08.013</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva JAJr, Araujo RC, Baltatu O, et al. Reduced cardiac hypertrophy and altered blood pressure control in transgenic rats with the human tissue kallikrein gene. FASEB J, 2000,14(13):1858–1860</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.99-1010fje</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu MY. Investigation on PI3K/Akt/NO signaling pathway involves in the protective effect of bradykinin against doxorubicin-induced myocardial cell damage. Hebei Medical University (Chinese), 2016</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>